It seems we can’t find what you’re looking for.
Last 28.05.2018 the European Commission published a Proposal of Regulation to modify Regulation No. 469/2009 on Supplementary Protection Certificates for medicaments. Basically, the proposal contemplates that, for SPCs granted
Spherium Biomed announced on May 17, 2018 that it has obtained positive results with its new drug Mucomel® in a phase I/IIa clinical trial for the
The United Kingdom announced on 26 April 2018, World Intellectual Property Day, that it has deposited the instruments of ratification of the Agreement relating to
This phase IIa clinical study in paediatric and adult patients with mild to moderate atopic dermatitis is designed as a proof-of-concept, multi-centre, randomised, double-blind, vehicle-controlled
Spherium Biomed has recently signed a licensing agreement with Simini Technologies from Ontario (Canada) to develop veterinarian applications based on the Spherium’s proprietary topical cyclosporine (SP14019).
We are pleased to announce that ABG Patentes will be hosting the fourth edition of the “IP Perspectives” seminar, which will be held on Thursday, 7 June 2018 at
We are pleased to announce that Jose Miguel Lissén has joined ABG IP as partner in charge of our new Legal & Litigation department. José Miguel Lissén is a lawyer and
Atlas Molecular Pharma, a private company founded in 2015 in Derio (Spain) as a spin-off from the Centre for Co-operative Research in Biosciences (CIC bioGUNE), receives approval
We are very proud to announce that on 8 March 2018 ABG IP received the“Patent Prosecution Firm of the Year” award for Spain at the 14th Annual Managing Intellectual Property (MIP)
“Setting up and management of innovative companies”, Dr. Pablo Calvo, European Patent Attorney and Partner at ABG’s electromechanical department will participate in the course to be held
ABG Patentes is participating in the largest European Event in Nanoscience & Nanotechnology, ImagineNano 2018, that is being held on 13-15 March in Bilbao, Spain. Our
As of 1 March 2018, a validation agreement between the EPO and the Government of the Kingdom of Cambodia will enter into force, by which
©2020 ABG Intellectual Law S.L. All Rights Reserved
